Impact of lifestyle modification practices and pharmacogenetics of ACE I/D gene polymorphism in grade 1 hypertensive patient

Abstract excerpt

<title>Abstract</title> <p>Background Hypertension is a chronic disease, prevalence of which is gradually increasing in the society. It causes disease burden for a country especially in low and middle-income countries. The present study aimed at analysing the impact of lifestyle modification practices and role of pharmacogenetics of anti-hypertensive drugs in hypertensive patients susceptible to <italic>ACE I/D<...

Topics

Open a Topic to create a Post that cites this publication.

• Angiotensin-Converting Enzyme Inhibitors
• Angiotensin Receptor Antagonists
• Angiotensinogen
• Nitric Oxide Synthase Type III
• Pakistan
• Peptidyl-Dipeptidase A
• Pharmacogenomic Testing
• Pharmacogenomic Variants

Identifiers and source

Literature Corpus work

bf5725d2-2120-5e44-a733-584932a5798c

DOI

10.21203/rs.3.rs-5406915/v1